Phantoms in the brain: Pain after ... ( This release is available in a href...)

Phantoms in the brain: Pain after amputation

Date:5/12/2008

This release is available in French.

Montreal, May 12, 2008 Losing a limb can be a traumatic experience and, in some cases, emotional and physical pain can linger for years. To better understand the phenomenon, dubbed phantom limb syndrome, Universit de Montral graduate student Emma Duerden is inviting amputees to come forward and share their experiences for a major study.

Our main goal is to better understand why amputees retain the memory of pain after losing a limb, explains Ms. Duerden, who is completing her doctorate in the laboratory of Dr. Gary Duncan at the Universit de Montrals Department of Physiology and the Centre de recherche de l'Institut universitaire de griatrie de Montral (CRIUGM).

People are born with a map of their body in their brain, she continues. After amputation, the representation of the body part still exists as a type of sensory memory. The map of the body becomes distorted and previous research has shown that this reorganization is linked to chronic pain. Our current goal is to study these organizational changes in the brain.

Ms. Duerden and her team will use high-resolution imaging techniques to explore the organization of the sensory maps in the brains of amputees. They will utilize new brain imaging software called real-time fMRI, which allows subjects to view their own brain activity while undergoing a scan.

We aim to develop techniques to help return amputees sensory map back to its original formation, says Ms. Duerden. We believe that patients can be trained to reorganize their internal map by focusing on their brain activity. This reorganization is believed to lead to a decrease in pain.

'/>"/>

Contact: Emma G. Duerden
emma.duerden@umontreal.ca
514-996-0500
University of Montreal
Source:Eurekalert

0

GOOD

Post Your Comments:

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... of Autoimmune Diseases Therapeutics - Market ... Pipeline and Deals Analysis ... Summary ,, The author has ...

(Date:12/15/2009)... -- Hosted by the Technology-based Learning SIG of ... 2009,s best eLearning designs. This year nominees, ... categories. The Venza Group entry, a highly ... hotelier, was selected as the winner of the ... by the panel of distinguished judges. While ...

(Date:12/15/2009)... and CHENNAI, India, Dec. 15 ... the world leader in generic injectable pharmaceuticals, ... 524372, NSE: ORCHIDCHEM), a leading Indian pharmaceuticals ... antibiotics manufacturers globally, today announced an agreement ... finished-dosage form pharmaceuticals business for approximately $400 ...

(Date:12/15/2009)... following is being released by the American Health Information ... MS, RHIT, CCS, FAHIMA ,, AHIMA President ... us... ,, On behalf of the A-H-I-M-A Board of ... chief executive officer, Doctor Alan Dowling... ,, Back last ... someone who we knew could effectively replace ...

(Date:12/15/2009)... often treated with hormones, but when the tumours start ... reveals a thesis from the Sahlgrenska Academy, at the ... for new treatments for hormone-resistant prostate cancer. , Late ... cancer has spread, most patients are given hormone therapy. ... and the tumour shrinks. , "The problem is that ...

[0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST [0] More blood vessels in hormone-resistant prostate tumors

... songwriters and authors have described, our memories range from misty ... our lives. , Now, a study led by researchers at ... new insights into the specific components of emotional memories, suggesting ... remember and what we forget. , Reported in the ...

... reported in publications and news,outlets throughout the world, a ... at the summer games opening show,s musical,for a child ... the globe, sadly, the phenomenon of making judgments about,others ... nothing new., In a study published more than ...

... Shearon raises awareness and donations for breast cancer,research/programs, ... difference and do his part to end cancer, as ... disease. He set a goal of walking 18,marathons in ... awareness and dollars,for breast cancer research and programs at ...

... of how long a heart must stop beating before death ... new reports challenge current guidelines on how long after cardiac ... infant organ donor. , There,s no question that organ donation ... enough donor organs to save everyone on the transplant list. ...

... Ex-Hill Committee on Aging Chief Robert Weiner Says ... Street,Giveaway Turning Guarantee to Gamble, WASHINGTON, Aug. ... ex-U.S. House Committee on Aging Chief of Staff,Robert ... through,privatization are a cry-wolf, granny-you,re-on-your-own, Wall Street,giveaway which ...

... a.m. Eastern ... Time, ... today reports operational and,financial results for the quarter ended June 30, 2008 ... ), "Alseres made solid progress in our programs during the second,quarter," ...

Other Medicine News:Health News:Study finds that sleep selectively preserves emotional memories 2 Health News:Study finds that sleep selectively preserves emotional memories 3 Health News:Summer Games 'Swap' Raises Questions About Image, Oral Health 2 Health News:More Than 400-mile Victory Walk to Conclude Aug. 14, at Campus Martius 2 Health News:More Than 400-mile Victory Walk to Conclude Aug. 14, at Campus Martius 3 Health News:Infant Heart Transplant Controversy Continues 2 Health News:Infant Heart Transplant Controversy Continues 3 Health News:Infant Heart Transplant Controversy Continues 4 Health News:Social Security's 73rd Anniversary 2 Health News:Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results 2 Health News:Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results 3 Health News:Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results 4 Health News:Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results 5 Health News:Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results 6

Study finds that sleep selectively preserves emotional memories Summer Games 'Swap' Raises Questions About Image, Oral Health More Than 400-mile Victory Walk to Conclude Aug. 14, at Campus Martius Infant Heart Transplant Controversy Continues Social Security's 73rd Anniversary Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results

(Date:12/15/2009)... 15 Estill Medical Technologies, Inc., a family-owned ... and IV Fluid Infusion Warmer , a patented medical ... military and emergency responders to lessen ... CALSTAR 6 Unit of South Lake Tahoe as the ... Year Award." ,, CALSTAR is a California-based ...

(Date:12/15/2009)... Decision Resources, one of the world,s leading research ... finds that an overall survival benefit would be ... European oncologists in their decision to prescribe a ... of breast cancer. ,, The new Special European ... Trends in Targeted Therapies in Breast Cancer: A ...

(Date:12/15/2009)... Mass., Dec. 15 OBP Medical Inc. ... and overall patient satisfaction in hospitals. ,, Doctors ... the positive effects of OBP Medical,s Under Johnnies(TM) ... stay. A hospital wide survey is comparing patients, ... their stay while wearing Under Johnnies(TM) against the ...

Breaking Medicine Technology:Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 2 Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 3 Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 4 For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2 For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3 Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 1 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 2 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 3 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 4 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 5 ULURU Inc Announces Status of York Note Receivable 52851 1 ULURU Inc Announces Status of York Note Receivable 52851 2 VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 1 VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 2

[0] Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award [0] For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe [0] Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc.

... Pharmaleads has obtained from the,French Medicine Agency (AFSSAPS) ... I study with PL37, its lead compound for ... a major chronic pain condition, with an estimated,prevalence ... according to the most,recent surveys, with many causes ...

... England, October 2 Circassia Ltd, a specialty,biopharmaceutical ... critical,care, today announced the start of a further ... the field of cat allergy. The trial builds ... study, which demonstrated,the potential clinical benefits of the ...

Other Medicine Technology:Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2 Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2

Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology

... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...

The GE e-Speed™scanner, the worlds fastest computed tomography (CT) imaging platform, delivers a new advanced tool for physicians to see and diagnose heart disease....

...

Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...

Medicine Products:

Surpass Superfusion Long EBT e-Speed™Vannas Straight Capsulotomy Scissors Corneal Section Scissors (Castroviejo) LEFT

Phantoms in the brain: Pain after ...( This release is available in a href...),Health